MedPath

Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity

Recruiting
Conditions
Carrier State
Respiratory Infections
Registration Number
NCT05474430
Lead Sponsor
Philip Polgreen
Brief Summary

A research team member will brush the inferior surface of the subjects' middle turbinate (nasal cavity) using a cytology brush to obtain the cells needed to perform our functional respiratory assays.

An individual trained in phlebotomy will draw one 3 ml lavender top tube of blood to test c-reactive protein, calprotectin, and lactoferrin. They will also draw a 5 ml gold top serum separator tube of blood to test fibroblast growth factor-19.

The participant will answer questions from the baseline survey and report their current medications interview-style with the research team member.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Previously tested and shown to be a CF carrier
  • English-speaking

Control Group Inclusion Criteria:

  • Previously tested and shown to not be a CF carrier or CF patient
  • English-speaking
Exclusion Criteria
  • Currently sick with a respiratory infection
  • Prisoner Status
  • Unable to provide own written, informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of Bicarbonate Transport ValuesAt baseline

Comparison of bicarbonate transport values in cystic fibrosis carrier group vs control group via t-test.

Comparison of Mucous Viscosity ValuesAt baseline

Comparison of mucous viscosity values in cystic fibrosis carrier group vs control group via t-test.

Comparison of Chloride Transport ValuesAt baseline

Comparison of chloride transport values in cystic fibrosis carrier group vs control group via t-test.

Comparison of Airway Surface Liquid pH ValuesAt baseline

Comparison of airway surface liquid pH values in cystic fibrosis carrier group vs control group via t-test.

Comparison of Bacterial Killing ValuesAt baseline

Comparison of bacterial killing values in cystic fibrosis carrier group vs control group via t-test.

Secondary Outcome Measures
NameTimeMethod
Comparison of Fibroblast Growth Factor-19 ValuesAt baseline

Comparison of fibroblast growth factor-19 values in cystic fibrosis carrier group vs control group via t-test.

Trial Locations

Locations (1)

University of Iowa Hospitals and Clinics

🇺🇸

Iowa City, Iowa, United States

© Copyright 2025. All Rights Reserved by MedPath